Literature DB >> 11084353

Muscular dystrophy: the worm turns to genetic disease.

J S Chamberlain1, G M Benian.   

Abstract

A new animal model for studying muscular dystrophy, a mutant form of the nematode Caenorhabditis elegans, brings the power of worm genetics to bear on the search for a cure for this disease; work on this worm has already led to the identification of a novel component that can suppress the mutant phenotype.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11084353     DOI: 10.1016/s0960-9822(00)00768-5

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  17 in total

1.  Learning cell biology as a team: a project-based approach to upper-division cell biology.

Authors:  Robin Wright; James Boggs
Journal:  Cell Biol Educ       Date:  2002

Review 2.  Duchenne's muscular dystrophy: animal models used to investigate pathogenesis and develop therapeutic strategies.

Authors:  C A Collins; J E Morgan
Journal:  Int J Exp Pathol       Date:  2003-08       Impact factor: 1.925

3.  Multi-environment model estimation for motility analysis of Caenorhabditis elegans.

Authors:  Raphael Sznitman; Manaswi Gupta; Gregory D Hager; Paulo E Arratia; Josué Sznitman
Journal:  PLoS One       Date:  2010-07-22       Impact factor: 3.240

4.  Loss of dystrophin and the microtubule-binding protein ELP-1 causes progressive paralysis and death of adult C. elegans.

Authors:  Jennifer L Hueston; Kathy A Suprenant
Journal:  Dev Dyn       Date:  2009-08       Impact factor: 3.780

Review 5.  Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy.

Authors:  David G Allen; Nicholas P Whitehead; Stanley C Froehner
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

6.  NemaFlex: a microfluidics-based technology for standardized measurement of muscular strength of C. elegans.

Authors:  Mizanur Rahman; Jennifer E Hewitt; Frank Van-Bussel; Hunter Edwards; Jerzy Blawzdziewicz; Nathaniel J Szewczyk; Monica Driscoll; Siva A Vanapalli
Journal:  Lab Chip       Date:  2018-07-24       Impact factor: 6.799

7.  Studying human disease genes in Caenorhabditis elegans: a molecular genetics laboratory project.

Authors:  Elisabeth A Cox-Paulson; Theresa M Grana; Michelle A Harris; Janet M Batzli
Journal:  CBE Life Sci Educ       Date:  2012       Impact factor: 3.325

Review 8.  Caenorhabditis elegans as a Model System for Duchenne Muscular Dystrophy.

Authors:  Rebecca A Ellwood; Mathew Piasecki; Nathaniel J Szewczyk
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 6.208

9.  Identification of potential therapeutic drugs for huntington's disease using Caenorhabditis elegans.

Authors:  Cindy Voisine; Hemant Varma; Nicola Walker; Emily A Bates; Brent R Stockwell; Anne C Hart
Journal:  PLoS One       Date:  2007-06-06       Impact factor: 3.240

10.  A decline in transcript abundance for Heterodera glycines homologs of Caenorhabditis elegans uncoordinated genes accompanies its sedentary parasitic phase.

Authors:  Vincent P Klink; Veronica E Martins; Nadim W Alkharouf; Christopher C Overall; Margaret H MacDonald; Benjamin F Matthews
Journal:  BMC Dev Biol       Date:  2007-04-19       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.